Ruanyun Edai gets Nasdaq notice after shares trade below $1 for 30 days

Bitget2026/10/09 21:20

Ruanyun Edai received a Nasdaq notice for failing the $1.00 minimum bid price rule following 30 consecutive business days below $1. The deficiency period ran from Aug. 25 through Oct. 6, 2026, breaching Nasdaq Capital Market Listing Rule 5550(a)(2). A 180-day compliance window runs to April 5, 2027; compliance requires at least $1.00 for 10 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing or trading. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ruanyun Edai Technology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610091720PRIMZONEFULLFEED9843090) on October 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Citi: French fiscal risks may cause ECB to pause rate hikes after December, euro likely to drop below 1.10

华尔街见闻•2026/10/10 07:43

Morgan Stanley raises CME Group price target to $337

格隆汇•2026/10/10 07:37

Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Chaincatcher•2026/10/10 07:19

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21